Cite
HARVARD Citation
Norris, S. et al. (2017). Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. British journal of clinical pharmacology. pp. 1815-1825. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Norris, S. et al. (2017). Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. British journal of clinical pharmacology. pp. 1815-1825. [Online].